BioSpace News Archive

TeraRecon, the leading provider of AI-driven advanced visualization solutions, has been awarded an expansion of their patent-protected AI interoperability platform.

OMNERA 500A Includes New Intelligent Automation Features to Help Improve Workflow and Efficiency, Without Compromising Patient Care

GE Healthcare unveiled a slate of new intelligently efficient solutions to help clinicians solve today’s two-part challenge of delivering high quality care while managing greater capacity and workflow issues, exacerbated by the impact of COVID-19.

Gannex, a wholly owned company of Ascletis Pharma Inc. and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announced that Melissa Palmer, MD, an internationally renowned Hepatologist, will join the Company as Chief Medical Officer, effective December 1, 2020.

Ascentage Pharma announced it has entered into an agreement with the University of Michigan, through which the company may obtain the exclusive global rights to a MDM2 protein degrader developed using the Proteolysis-Targeting Chimeras technology.

Toyoda Gosei Co., Ltd. has invested1 in Ball Wave Inc., a startup from Tohoku University that develops practical applications of ball SAW sensors.2 These sensors use natural collimation of surface acoustic waves, a physical phenomenon predicted and experimentally verified by researchers at Tohoku University, and can instantly detect various kinds of matter in air and other gases at the nanoscale.

At this year’s virtual RSNA congress, Ziehm Imaging showcases its leading portfolio of mobile C-arms and advanced imaging solutions.

Showcasing Advanced intelligent Clear-IQ Engine Deep Learning Reconstruction Technology on Wider Range of Clinical Applications, More Modalities and Systems

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the UK government for an additional 2 million doses of mRNA-1273, Moderna’s vaccine candidate against COVID-19, to the United Kingdom beginning in March 2021.

Sorrento Therapeutics, Inc., is pleased to announce that Dr. Henry Ji, Chairman and CEO, will be participating in the Piper Sandler 32nd Annual Virtual Healthcare Conference.